BioSight Company

BioSight is a biopharmaceutical private company founded in 2000 and re launched in mid 2009, revolutionizing the research and development of innovative cancer targeted pro-drugs. BioSight has developed technology S2DOT TM and a pipeline of targeted pro-drugs, that can target and release chemotherapy drugs inside cancer cells, while significantly minimizing the systemic toxicity associated with conventional chemotherapy ​​treatments.​​​
Technology: P4 Medicine
Industry: Personalized Medicine
Headquarters: Carmiel, Israel
Founded Date: 2000
Employees Number: 11-50
Funding Status: N/A

Visit Website
Register and Claim Ownership